Arch Therapeutics Inc (ARTH)

[bryan2464]

By Harriet Lefton on TalkMarkets website:

The US Securities and Exchange Commission (SEC) is taking legal action against 27 individuals and several companies over hundreds of fake “impartial” blog posts that appeared on well-known financial websites.
In many cases- about 250 articles- the bloggers were secretly paid to write bullish articles to promote mainly small biotech stocks such as Lion Biopharma (LBIO), Arch Therapeutics (ARTH), Galena Biopharma (GALE) and Oncosec Medical (ONCS).